Can Serologic Markers Help Determine Prognosis and Guide Therapy?

Publisher： Karger

E-ISSN： 1421-9875|28|3|424-428

ISSN： 0257-2753

Source： Digestive Diseases, Vol.28, Iss.3, 2010-09, pp. : 424-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biochemical Markers as a Response Guide for Steroid Therapy in Asthma

By Al Obaidi Amina   Samarai Abdulghani Mohamad Al  

Journal of Asthma, Vol. 45, Iss. 5, 2008-06 ,pp. : 425-428

Informa Healthcare

Access to resources Recommend Favorite

New Serologic Markers for Inflammatory Bowel Disease Diagnosis

By  

Digestive Diseases, Vol. 28, Iss. 3, 2010-09 ,pp. : 418-423

Karger

Access to resources Recommend Favorite

Impaired Quality of Life in Hypopituitary Adults with Growth Hormone Deficiency: Can Somatropin Replacement Therapy Help?

By Jan Berend Deijen  

Treatments in Endocrinology, Vol. 5, Iss. 4, 2006-01 ,pp. : 243-250

Adis International

Access to resources Recommend Favorite

Emerging New Markers of Stroke Risk and Prognosis

By  

European Neurology, Vol. 72, Iss. 1-2, 2014-06 ,pp. : 79-80

Karger

Access to resources Recommend Favorite

Can Drug Effects Help Elucidate the Pathogenesis of SLE?

By  

Current Rheumatology Reviews, Vol. 2, Iss. 3, 2006-08 ,pp. : 233-244

Bentham Science Publishers

Access to resources Recommend Favorite